Clinical outcomes are complex and often involve multiple systemic burdens. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological evaluations.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnoses and treatment programs. Treatment and management of patients with coronavirus requires individualized development, usually including multidimensional management, such as drug therapy, rehabilitation, and regular follow-up visits. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that have previously been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in conditions. Multidisciplinary collaboration (MDT) is especially important for the integrated management of Kawasaki coronary thrombosis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.